You have seen them. The patients who walk into your clinic with a peptide shopping list, asking for semaglutide for weight loss and BPC 157 for joint pain, while surviving on four The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA Compliance for Peptide Therapy and BPC 157 Holt Law